Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
3.635
+0.075 (2.11%)
Mar 9, 2026, 2:17 PM EDT - Market open
Cellectis Market Cap
Cellectis has a market cap or net worth of $273.34 million as of March 9, 2026. Its market cap has increased by 146.25% in one year.
Market Cap
273.34M
Enterprise Value
309.51M
1-Year Change
146.25%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $273.34M, a decrease of -79.66%. That is a compound annual growth rate of -13.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 257.50M | -26.45% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AC Immune | 276.05M |
| OmniAb | 273.64M |
| Coherus Oncology | 272.04M |
| Enlivex | 270.61M |
| Prelude Therapeutics | 266.14M |
| Fennec Pharmaceuticals | 262.98M |
| Abeona Therapeutics | 262.83M |
| Cybin | 262.69M |